Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.90
+0.02 (0.43%)
May 1, 2026, 11:50 AM EDT - Market open
Annexon Market Cap
Annexon has a market cap or net worth of $957.98 million as of May 1, 2026. Its market cap has increased by 467.01% in one year.
Market Cap
957.98M
Enterprise Value
741.77M
1-Year Change
467.01%
Ranking
Category
Stock Price
$5.90
Market Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $957.98M, an increase of 49.80%. That is a compound annual growth rate of 7.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 953.92M | 27.48% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 1.04B |
| ORIC Pharmaceuticals | 991.54M |
| Geron | 986.99M |
| Maravai LifeSciences Holdings | 946.01M |
| CytomX Therapeutics | 918.67M |
| SELLAS Life Sciences Group | 913.44M |
| LB Pharmaceuticals | 909.30M |
| Alto Neuroscience | 899.45M |